New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 3, 2014
12:25 EDTARTC, ZMH, JNJ, GMED, COV, WMGI, SNN, SYK, NUVAAnother bidder may emerge for ArthroCare, says William Blair
William Blair says it would not be surprised to see another bidder emerge for ArthroCare (ARTC). The firm lists Johnson & Johnson (JNJ) and Stryker (SYK)) as the most likely to submit a competing bid to Smith & Nephew's (SNN), and notes Biomet, Zimmer (ZMH) and Covidien (COV) could also have interest in the company. Should the deal for ArthroCare close as currently contemplated, William Blair thinks peers Globus Medical (GMED), NuVasive (NUVA) and Wright Medical (WMGI) could be takeover targets.
Check below for free stories on ARTC;SNN;GMED;NUVA;WMGI;JNJ;SYK;COV;ZMH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 17, 2014
14:39 EDTSYKStryker backs Q3 adjusted EPS $1.12-$1.16, consensus $1.14
Subscribe for More Information
14:36 EDTSYKStryker says globalization remains a 'top priority'
Subscribe for More Information
08:36 EDTJNJJanssen-Cilag announces results from post-hoc canagliflozin analysis
Subscribe for More Information
08:12 EDTJNJJanssen-Cilag announces results from Phase 3 Invokana trial
Subscribe for More Information
07:43 EDTSNNBofA/Merrill to hold a conference
Subscribe for More Information
September 16, 2014
11:51 EDTCOVOECD looks to close tax loopholes with new proposals
Subscribe for More Information
07:31 EDTJNJEuropean Association for Study of Diabetes to hold annual meeting
50th Annual Meeting of EASD to be held in Vienna, Austria on September 15-19.
September 15, 2014
10:27 EDTSYKStryker to host analyst meeting with a conference call hook-up available
Analyst meeting to be held in Mahwah, NJ on September 17 at 2:30 pm. Webcast Link
07:27 EDTJNJIBC Life Sciences to hold a conference
Subscribe for More Information
07:04 EDTCOVCovidien announces start of enrollment in two neurovascular trials
Covidien announced the start of enrollment in two clinical trials designed to further underscore the safety and effectiveness of the company’s advanced neurovascular solutions. Baptist Medical Center in Jacksonville, Florida, treated the first patient enrolled in the PREMIER Prospective study, an international Investigational Device Exemption clinical study to evaluate the Pipeline embolization device in smaller unruptured intracranial aneurysms. Separately, Baptist Health Lexington in Kentucky, enrolled the first patient in the STRATIS Registry for Endovascular Stroke Devices, which will evaluate the use of all Covidien market-released stroke devices. The PREMIER study will enroll up to 141 patients in 20 global sites and is designed to assess the safety and effectiveness of the Pipeline device in the treatment of unruptured, small and medium wide-necked intracranial aneurysms. The STRATIS Registry, a prospective, multi-center, non-randomized, observational registry designed to evaluate the use of Covidien endovascular stroke devices in patients diagnosed with an acute ischemic stroke. Covidien’s current endovascular stroke device in the U.S. is the Solitaire™ 2 revascularization device. As many as 60 U.S. sites are expected to participate in the STRATIS Registry, which will enroll up to 1,000 patients to collect clinical outcomes for interventional stroke patients in a real world setting.
September 12, 2014
14:16 EDTARTCWater Island Capital reports 11.01% passive stake in ArthroCare
September 11, 2014
16:15 EDTWMGIVisium Asset Management reports 4.8% passive stake in Wright Medical
07:19 EDTGMEDGlobus Medical reiterated as top pick at Piper Jaffray
Piper Jaffray reiterates Globus Medical as a top pick and raised its price target for shares to $28 from $26. Piper views the stock's valuation as among the most compelling in its coverage universe. It believes Globus' underlying business is solid and reiterates an Overweight rating on the stock. JMP Securities this morning initiated Globus Medical with an Outperform rating and $25 price target.
07:11 EDTJNJMedivation price target raised to $112 from $89 at Stifel
Subscribe for More Information
06:24 EDTGMEDGlobus Medical initiated with an Outperform at JMP Securities
Subscribe for More Information
September 10, 2014
11:06 EDTWMGIHigh option volume stocks
Subscribe for More Information
10:14 EDTJNJJohnson & Johnson says off to 'very good start' this year
Subscribe for More Information
September 9, 2014
06:42 EDTCOVLew expects to make decision on combating inversion deals soon, NY Times reports
Subscribe for More Information
06:34 EDTZMHZimmer price target raised to $148 from $119 at Piper Jaffray
Subscribe for More Information
September 8, 2014
11:05 EDTCOVOptions with increasing implied volatility
Options with increasing implied volatility: NPSP GILD VNET AVNR GTAT YHOO RHT VRTX SDRL COV MYL
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use